Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Basal Cell × Biological Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia, Myeloid, Acute 2 Congenital Abnormalities 2 Colonic Neoplasms 2 Waldenstrom Macroglobulinemia 1 Vipoma 1 Uterine Cervical Dysplasia 1 Urologic Neoplasms 1 Thrombocythemia, Essential 1 Squamous Intraepithelial Lesions 1 Somatostatinoma 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, AIDS-Related 1 Lymphoma 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

HhAntag691 13 Aminolevulinic Acid 5 sonidegib 4 Nivolumab 3 tazarotene 2 daromun 2 cemiplimab 2 Specimen Handling 2 Radiotherapy 2 IPI-926 2 Drug Evaluation 2 Celecoxib 2 3-ingenyl angelate 2 talimogene laherparepvec 1 remetinostat 1 relatlimab 1 endonuclease V, phage T4 1 Triamcinolone 1 Sutures 1 Surgical Procedures, Operative 1 Solutions 1 Papillomavirus Vaccines 1 Opdualag 1 Niacinamide 1 NVP-BKM120 1 Methotrexate 1 Magnetic Resonance Spectroscopy 1 Lighting 1 Ipilimumab 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00025051 2013-03-22

Celecoxib in Preventing Skin Cancer

National Cancer Institute (NCI)

Phase 2 Withdrawn

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡